CAR-T cell therapy is approved by the FDA for several subtypes of lymphoma, such as:  

• Follicular lymphoma (FL)
• Large B-cell lymphoma (LBCL)
• Mantle cell lymphoma (MCL)
• Small lymphocytic lymphoma (SLL)

Although other types of lymphoma do not yet have FDA-approved CAR T-cell therapies, clinical trials may be available that offer CAR-T for your specific type of lymphoma. Ask your lymphoma specialist about available trials. You can also learn more in our guide section: The Future of CAR-T for Lymphoma.